Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Warns Pharmacy About Illegal GLP-1 Compounding

(MedPage Today) -- The FDA issued a warning letter this month to Empower Pharmacy over its mass production of compounded GLP-1 weight-loss and diabetes drugs, citing illegal copycat manufacturing and insanitary conditions. Following a facility...

FDA Warns Pharmacy About Illegal GLP-1 Compounding

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

New Liposome Design Could Provide Effective Slow-Release Drug Delivery System

A slow-release liposome system delivered local anesthesia for weeks in rats, potentially enabling longer-lasting nerve blocks and new approaches to pain management.

  • New liposome design provides two to three weeks of pain-numbing effects in rats
  • Fluid lipids in liposomes release hydrophilic drugs slowly, reducing toxicity
  • Multilayered liposome structure creates multiple compartments, slowing drug release

More from Wednesday 23 September →